Tadekinig Alfa, a recombinant human IL-18 binding protein, is being tested in adult onset Still’s disease and in NLRC4 related macrophage activation syndrome (inflammatory diseases associated with high plasma IL-18 levels) (ClinicalTrials.gov Identifier: NCT02398435, NCT03113760). The gene discussed is NLRC4; the disease is adult-onset Still disease.